600833 Shanghai No.1 Pharmacy
WatchlistShanghai No.1 Pharmacy News
Shanghai No.1 Pharmacy to Get 185.3 Million Yuan to Relocate Operations
Shanghai No.1 Pharmacy (SHA:600833) and its subsidiary Shanghai Great Wall Huamei Instrument Chemical agreed to receive a total of 185.3 million yuan in compensation for relocating their operations. T
First Pharmaceutical (600833.SH): The company and its wholly-owned subsidiary sign a housing expropriation compensation agreement
On November 20, Gelonghui (600833.SH) announced that after many negotiations, a basic agreement has now been reached on expropriation compensation matters. Our company and Great Wall Huamei plan to sign the “Housing Expropriation Compensation Agreement on State-owned Land in Shanghai” and the “Settlement Form for 79 Neighborhoods (Enterprises and Institutions) in Huangpu District” with housing expropriation units and housing expropriation implementation units. According to the compensation agreement, our company and Great Wall Huamei expect to receive a total of 185,308,877.14 yuan in expropriation compensation for these four houses, of which our company will receive 129,701,495.64 yuan, and Great Wall Huamei will receive 55,60 yuan
CITIC Construction Investment: The pharmacy industry has strong expectations of marginal improvement in operations, and there are allocation opportunities
The operating pace of the pharmacy industry is expected to improve sequentially in '24, and valuations have entered a low level.
First Medicine (600833.SH): Received 355.38,400 yuan in compensation from housing expropriation
Gelonghui (600833.SH) announced on November 6|First Pharmaceutical () announced that the company held the 11th (interim) meeting of the 10th board of directors on June 15, 2023, deliberated and passed the “Proposal on Signing a Housing Expropriation Compensation Agreement”, and signed the “Shanghai State-owned Land Housing Expropriation Compensation Agreement” and the “Settlement Form for Enterprises and Institutions for the Renovation Project of 190 Neighborhood Old Town in Huangpu District” (hereinafter referred to as the “Compensation Agreement”) with housing expropriation units and housing expropriation implementation units. According to the compensation agreement, the company expects to receive a total of 355.384 million yuan in expropriation compensation for this house. Recently, the company
First Pharmaceutical (600833.SH) released its first three quarter results, net profit of 57.508 million yuan, a year-on-year decrease of 22.85%
First Pharmaceutical (600833.SH) released its report for the third quarter of 2023. The company achieved revenue of 1 in the first three quarters...
First Pharmaceutical (600833.SH): The company's inventory and sales of azithromycin-related products are normal
Glonghui, Oct. 25丨An investor asked First Pharmaceutical (600833.SH) on the investor interactive platform, “How is your azithromycin reserve? How's the sales volume?” The company stated that the company's inventory and sales volume of azithromycin-related products are normal.
First Pharmaceutical (600833.SH): The company is currently not directly involved in the drug manufacturing business
Glonghui, Oct. 25丨An investor asked No.1 Pharmaceutical (600833.SH) on the investor interactive platform, “Has your company participated in manufacturing drugs recently, and what drugs have they manufactured?” The company said that it is currently not directly involved in the pharmaceutical manufacturing business.
RooLife Secures $2 Million Order From Shanghai No.1 Pharmaceuticals
RooLife (ASX:RLG) secured a AU$1.95 million order for products to be ranged at Shanghai No.1 Pharmaceuticals' (SHA:600833) physical stores in China, the e-commerce firm said on Monday. The collaborati
First Pharmaceutical (600833.SH): As of June 30, the company had 148 stores
Glonghui, September 22, 丨 First Pharmaceutical (600833.SH) said at the semi-annual performance briefing that as of June 30, 2023, the company had 148 stores (including 9 franchise stores). From January to June 2023, the company had a net increase of 10 stores, including 14 new stores, 1 new affiliate store, and 5 closed stores. In the future, the company will focus on a 15-minute life circle, speed up the filling of empty areas in outlets and encryption in key areas, promote channel expansion at terminal outlets, and increase the coverage of store services.
First Pharmaceutical (600833.SH) reported semi-annual results, net profit of 458.29,600 yuan, an increase of 38.19% over the previous year
First Pharmaceutical (600833.SH) released the 2023 semi-annual report, with revenue of 888 million yuan, year-on-year...
Pharmaceutical stocks collectively rebounded, Fangsheng Pharmaceutical rose more than 7%
Glonway June 27丨Fangsheng Pharmaceutical and First Pharmaceutical rose more than 7%, while Kangyuan Pharmaceutical, Yuheng Pharmaceutical, Xingqi Eye Medicine, and Nanxin Pharmaceutical all rose.
First Pharmaceutical (600833.SH): The subsidiary intends to rent stores from related parties
Gelonhui June 15 丨 First Pharmaceutical (600833.SH) announced that Shanghai First Pharmaceutical HSBC Pharmacy Co., Ltd., a wholly-owned subsidiary, plans to sign three “Property Lease Contracts” with Shanghai Bailian Xuhui Shopping Plaza Co., Ltd. to lease G49-01F01-0102, G49-01F01-01-0103, G49-01F01-0102,, G49-01F01-01-0104, with a total leasing area of 829.67 square meters, respectively Area 509 square meters, contract
First Pharmaceutical (600833.SH) signed a housing expropriation compensation agreement to collect compensation totaling 355.384 million yuan
According to the Zhitong Finance App, First Pharmaceutical (600833.SH) issued an announcement. According to the “Shanghai Huangpu District People's Government Housing Expropriation Decision” (Huangfu Zheng [2022] No. 1) issued by the Shanghai Huangpu District People's Government on February 10, 2022, the company's house located at No. 10 Jiangxi Middle Road, Huangpu District, Shanghai was included in the scope of expropriation. The expropriated housing on Jiangxi Middle Road was used by the company for external rental operations (it has now been taken back). The housing expropriation unit this time is “Shanghai Huangpu District Housing Security and Housing Administration”, and the implementing unit of housing expropriation is “Shanghai Huangpu Second Housing Expropriation Service Co., Ltd.
The registration date for First Pharmaceutical (600833.SH) to distribute shares of 0.195 yuan per share in 2022 is June 15
According to the Zhitong Finance App, First Pharmaceutical (600833.SH) announced that the company will implement the 2022 annual equity distribution, with a cash dividend of 0.195 yuan (tax included) per share. The equity registration date is June 15.
Pharmaceutical commercial stocks rose higher, First Pharmaceutical rose more than 8%
Gelonghui, June 5, 丨 First Pharmaceutical rose more than 8%, Heavy Pharmaceutical Holdings rose more than 7%, and Tesco, Sinopharm, Sinopharm, and Renmin Tongtai followed suit.
First Pharmaceutical (600833.SH) released first-quarter results, with net profit of 29.61 million yuan, an increase of 373.18% over the previous year
According to the Zhitong Finance App, First Pharmaceutical (600833.SH) disclosed its report for the first quarter of 2023. During the reporting period, the company achieved revenue of 459 million yuan, an increase of 17.29% over the previous year; Guimu's net profit of 29.61 million yuan, an increase of 373.18% over the previous year; after deducting non-net profit of 7.88 million yuan, an increase of 28.8% over the previous year; and basic earnings per share of 0.1327 yuan.
First Pharmaceutical (600833.SH): Net profit increased 190.49% to 144 million yuan in 2022, proposed 10 distribution of 1995 yuan
Gelonhui, March 31, 丨 First Pharmaceutical (600833.SH) announced its 2022 annual report. During the reporting period, it achieved operating income of 2,656 million yuan, an increase of 89.94% over the previous year; net profit attributable to shareholders of listed companies was 144 million yuan, an increase of 190.49% over the previous year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 140 million yuan, an increase of 504.38% over the previous year; and basic earnings per share of 0.64 yuan. It is proposed to distribute a cash dividend of 1.95 yuan (tax included) for every 10 shares to all shareholders.
First Pharmaceutical (600833.SH) received 8.417,600 yuan in housing expropriation compensation
According to the Zhitong Finance App, First Pharmaceutical (600833.SH) issued an announcement that the company concerned located on the ground floor and second floor and 602 two-story houses located at No. 608 Niuzhuang Road, Huangpu District, Shanghai were included in the scope of expropriation. Recently, the company received a total compensation of 8,417,600 yuan for this housing expropriation. At this point, the compensation agreements signed by the company with the housing expropriation unit and the housing expropriation implementing unit have all been fulfilled.
First Pharmaceutical (600833.SH) received 258.14,300 yuan in compensation for related housing expropriation
According to the Zhitong Finance App, First Pharmaceutical (600833.SH) issued an announcement. Recently, the company actually received a total of 258.14,300 yuan in compensation. At this point, the compensation agreements signed by the company with the housing expropriation unit and the housing expropriation implementing unit have all been fulfilled.
Express News | The opening of the pharmaceutical business sector declined